image
Healthcare - Biotechnology - NASDAQ - US
$ 22.04
-0.136 %
$ 3.74 B
Market Cap
-9.97
P/E
IMVT - COST OF REVENUE

Cost of Revenue IMVT - Immunovant, Inc.

image
231 K
LAST VALUE
-56.70%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR